Multi-modal regulation of endogenous D1 dopamine receptor expression and function in the CAD catecholaminergic cell line

Journal of Neurochemistry

Volumn 89, Issue 6, 2004, Pages 1508-1519

  Pasuit, Jennifer B ^a   Li, Zhuting ^a   Kuzhikandathil, Eldo V ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Adenylyl cyclase; Differentiation; Neurotrophin; Signal transduction; Transcription; Translation

Indexed keywords

ADENYLATE CYCLASE; CELL SURFACE RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; MESSENGER RNA; NEUROTROPHIN 3; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CATECHOLAMINE NERVE CELL; CELL SPECIFICITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; RNA STABILITY; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ADENYLATE CYCLASE; ANIMALS; BLOTTING, WESTERN; CATECHOLAMINES; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; MICE; NEURONS; NEUROTROPHIN 3; NUCLEASE PROTECTION ASSAYS; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RECEPTORS, DOPAMINE D1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

ANIMALIA;

EID: 3042517273     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02450.x     Document Type: Article

References (22)

1. Bermak J. C., Li M., Bullock C. and Zhou Q. Y. (2001) Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 3, 492-498.
2. Butkerait P. and Friedman E. (1993) Repeated reserpine increases striatal dopamine receptor and guanine nucleotide binding protein RNA. J. Neurochem. 60, 566-571.
3. Cai J. X. and Amsten A. F. (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J. Pharmacol. Exp. Ther. 283, 183-189.
4. Hanoune J. and Defer N. (2001) Regulation and role of adenylyl cyclase isoforms. Annu. Rev. Pharmacol. Toxicol. 41, 145-174.
5. Hashemi S. H., Li J. Y., Faigle R. and Dahlstrom A. (2003) Adrenergic differentiation and SSR2a receptor expression in CAD-cells cultured in serum-free medium. Neurochem. Int. 42, 9-17.
6. Hersi A. I., Rowe W., Gaudreau P. and Quirion R. (1995) Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 69, 1067-1074.
7. Horton C. D., Qi Y., Chikaraishi D. and Wang J. K. (2001) Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line. J. Neurochem. 76, 201-209.
8. Jarvie K. R., Booth G., Brown E. M. and Niznik H. B. (1989) Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland. Mol. Pharmacol. 36, 566-574.
9. Johnston C. A., Beazely M. A., Vancura A. F., Wang J. K. and Watts V. J. (2002) Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells. J. Neurochem. 82, 1087-1096.
10. Laurier L. G., O'Dowd B. F. and George S. R. (1994) Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain. Brain Res. Mol. Brain Res. 25, 344-350.
11. Lazaroff M., Qi Y. and Chikaraishi D. M. (1998) Differentiation of a catecholaminergic CNS cell line modifies tyrosine hydroxylase transcriptional regulation. J. Neurochem. 71, 51-59.
12. Lee S.-H., Monowa M. T. and Mouradian M. M. (1996) Two distinct promoters drive transcription of the human D1A dopamine receptor gene. J. Biol. Chem. 271, 25292-25299.
13. Marshall J. F. and Berrios N. (1979) Movement disorders of aged rats: reversal by dopamine receptor stimulation. Science 206, 477-479.
14. Missale C., Nash S. R., Robinson S. W., Jaber M. and Caron M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225.
15. Petaja-Repo U. E., Hogue M., Laperriere A., Walker P. and Bouvier M. (2000) Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human δ opioid receptor. J. Biol. Chem. 275, 13727-13736.
16. Qi Y., Wang J. K., McMillian M. and Chikaraishi D. M. (1997) Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J. Neurosci. 17, 1217-1225.
17. Rasmussen R. (2001) Quantification on the lightcycler. In: Rapid Cycle Real-Time PCR, Methods and Applications (Meuer, S., Wittwer, C. and Nakagawara., eds), pp. 21-34. Springer Verlag, Heidelberg, Germany.
18. Rogue P., Hanauer A., Zwiller J., Malviya A. N. and Vincendon G. (1991) Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment. Eur. J. Pharmacol. 207, 165-168.
19. Schambra U. B., Duncan G. E., Breese G. R., Fomaretto M. G., Caron M. G. and Fremeau R. T. Jr (1994) Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62, 65-85.
20. Stoessl A. J. and de la Fuente-Femandez R. (2003) Dopamine receptors in Parkinson's disease: imaging studies. Adv. Neurol. 91, 65-71.
21. Wang H. and Oxford G. S. (2000) Voltage-dependent ion channels in CAD cells: a catecholaminergic neuronal line that exhibits inducible differentiation. J. Neurophysiol. 84, 2888-2895.
22. Xu S. X., Monsma F. J. Jr, Sibley D. R. and Creese I. (1992) Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. Life Sci. 50, 383-396.